Voice your opinion on congressional bill S1391-116 and let lawmakers know your stance with UnPac!

Main Subject: Health

Fair Accountability and Innovative Research Drug Pricing Act of 2019

This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.

HR2296-116, S1895-116,

Senate Actions

IntroReferral
May. 09 2019	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Library of Congress Actions

IntroReferral
May. 09 2019	Introduced in Senate

Senate bill S1391-116

Fair Accountability and Innovative Research Drug Pricing Act of 2019

Promote the cause!

Or use this QR code